Who owns Etf Ser Solutions loncar cancer?
- Ticker: CNCR
- CUSIP Number: 26922a826
Tip: Access positions for across all investors
Analyze quarterly positions in Etf Ser Solutions loncar cancer with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Etf Ser Solutions loncar cancer stock
Who bought or sold Etf Ser Solutions loncar cancer this quarter?
Fund or Company Name |
Shares Held |
Valued At |
Change in Shares |
As Of |
Actions |
|---|---|---|---|---|---|
| Susquehanna International | 45k | $550k | 305% | Dec 2024 |
|
| Colony | 37k | $460k | 0% | Dec 2024 |
|
| Jane Street | 17k | $205k | 100% | Dec 2024 |
|
| UBS Group | 4.6k | $57k | -14% | Dec 2024 |
|
| Morgan Stanley | 3.6k | $44k | -29% | Dec 2024 |
|
| Advisor Group Holdings | 847.00 | $10k | 301% | Dec 2024 |
|
| Blue Bell Private Wealth Management | 723.00 | $8.9k | 0% | Dec 2024 |
|
| Royal Bank of Canada | 309.00 | $3.8k | 375% | Dec 2024 |
|
| Newbridge Financial Services Group | 300.00 | $3.7k | 0% | Dec 2024 |
|
| Wells Fargo & Company | 250.00 | $3.1k | 100% | Dec 2024 |
|
| Goss Wealth Management | 150.00 | $1.8k | 50% | Dec 2024 |
|